You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Aflibercept for treating diabetic macular oedema

  • Technology appraisal guidance
  • Reference number: TA346
  • Published:  22 July 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Macular oedema (diabetic) - aflibercept: final appraisal determination document

Macular oedema (diabetic) - aflibercept: final appraisal determination document Macular oedema (diabetic) - aflibercept: final appraisal determination document
02 June 2015
(421.67 Kb 2 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 28 May 2015

Back to top